These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 22706858)

  • 1. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas.
    Liu H; Shi J; Wilkerson ML; Lin F
    Am J Clin Pathol; 2012 Jul; 138(1):57-64. PubMed ID: 22706858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
    Fatima N; Osunkoya AO
    Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiquantitative GATA-3 immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas.
    Clark BZ; Beriwal S; Dabbs DJ; Bhargava R
    Am J Clin Pathol; 2014 Jul; 142(1):64-71. PubMed ID: 24926087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
    Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma.
    So JS; Epstein JI
    Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
    Esheba GE; Longacre TA; Atkins KA; Higgins JP
    Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin.
    Bezerra SM; Lotan TL; Faraj SF; Karram S; Sharma R; Schoenberg M; Bivalacqua TJ; Netto GJ
    Hum Pathol; 2014 Aug; 45(8):1682-7. PubMed ID: 24925221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of GATA3 immunostaining in tumor diagnosis: a review.
    Ordóñez NG
    Adv Anat Pathol; 2013 Sep; 20(5):352-60. PubMed ID: 23939152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract.
    Gulmann C; Paner GP; Parakh RS; Hansel DE; Shen SS; Ro JY; Annaiah C; Lopez-Beltran A; Rao P; Arora K; Cho Y; Herrera-Hernandez L; Alsabeh R; Amin MB
    Hum Pathol; 2013 Feb; 44(2):164-72. PubMed ID: 22995333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
    Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE
    Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of uroplakin II expression as a marker of urothelial carcinoma.
    Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
    Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas.
    Liu H; Shi J; Prichard JW; Gong Y; Lin F
    Am J Clin Pathol; 2014 May; 141(5):648-55. PubMed ID: 24713735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.
    Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS
    Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3 expression in metastatic urothelial carcinoma in fine needle aspiration cell blocks: a review of 25 cases.
    Siddiqui MT; Seydafkan S; Cohen C
    Diagn Cytopathol; 2014 Sep; 42(9):809-15. PubMed ID: 24578300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens.
    Braxton DR; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2015 Apr; 43(4):271-7. PubMed ID: 25088841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinomas of the Gynecologic Tract Involving the Urinary Bladder: A Series of 16 Cases Potentially Mimicking Urothelial Malignancy.
    Russell DH; Epstein JI; Kryvenko ON; Schlumbrecht M; Jorda M; Pinto A
    Arch Pathol Lab Med; 2024 Jun; 148(6):705-714. PubMed ID: 37948107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis.
    Mehra R; Varambally S; Ding L; Shen R; Sabel MS; Ghosh D; Chinnaiyan AM; Kleer CG
    Cancer Res; 2005 Dec; 65(24):11259-64. PubMed ID: 16357129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.